BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7497137)

  • 1. Effect of breast cancer screening after age 65.
    Chen HH; Tabar L; Fagerberg G; Duffy SW
    J Med Screen; 1995; 2(1):10-4. PubMed ID: 7497137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.
    Tabar L; Fagerberg G; Chen HH; Duffy SW; Gad A
    J Med Screen; 1995; 2(2):94-8. PubMed ID: 7497163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
    Jonsson H; Nyström L; Törnberg S; Lenner P
    J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
    Swedish Organised Service Screening Evaluation Group
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess mortality from breast cancer in relation to mammography screening in northern Sweden.
    Lenner P; Jonsson H
    J Med Screen; 1997; 4(1):6-9. PubMed ID: 9200054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.
    Tabar L; Yen MF; Vitak B; Chen HH; Smith RA; Duffy SW
    Lancet; 2003 Apr; 361(9367):1405-10. PubMed ID: 12727392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gothenburg Breast Screening Trial.
    Bjurstam N; Björneld L; Warwick J; Sala E; Duffy SW; Nyström L; Walker N; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Salander H; Säve-Söderbergh J; Wahlin T
    Cancer; 2003 May; 97(10):2387-96. PubMed ID: 12733136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes.
    Törnberg S; Carstensen J; Hakulinen T; Lenner P; Hatschek T; Lundgren B
    J Med Screen; 1994 Jul; 1(3):184-7. PubMed ID: 8790514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
    Tabár L; Vitak B; Chen TH; Yen AM; Cohen A; Tot T; Chiu SY; Chen SL; Fann JC; Rosell J; Fohlin H; Smith RA; Duffy SW
    Radiology; 2011 Sep; 260(3):658-63. PubMed ID: 21712474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography screening and breast cancer mortality in Sweden.
    Autier P; Koechlin A; Smans M; Vatten L; Boniol M
    J Natl Cancer Inst; 2012 Jul; 104(14):1080-93. PubMed ID: 22811439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Erikson O; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säwe-Söderberg J
    J Natl Cancer Inst Monogr; 1997; (22):53-5. PubMed ID: 9709276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.
    Zackrisson S; Andersson I; Janzon L; Manjer J; Garne JP
    BMJ; 2006 Mar; 332(7543):689-92. PubMed ID: 16517548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated results of the Gothenburg Trial of Mammographic Screening.
    Bjurstam NG; Björneld LM; Duffy SW
    Cancer; 2016 Jun; 122(12):1832-5. PubMed ID: 27061821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results.
    Tabar L; Vitak B; Chen HH; Prevost TC; Duffy SW
    Swiss Surg; 1999; 5(5):199-204. PubMed ID: 10546517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.